Fundz

Medical marvel: This female-founded startup uses 3D bioprinting to mimic tumour environment for cancer treatment, gets £4.2M funding

PRIVATEJan 29, 2024

Amount Raised

£4.2 Million

Round Type

Funding Round

EdinburghBiotechnology Research

Investors

Alba EquityGabriel InvestmentSIS VenturesTricapitalInvesting WomenOld College CapitalScottish EnterpriseMaven Capital PartnersEos Advisory

Description

Carcinotech has raised £4.2 million in its latest funding round to advance its Carcino3D technology and expand its operations in the UK, Europe, and the US.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as Carcinotech Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Baseimmune raised $11M (Series A) on February 26, 2024.
  • eFeed raised $10M (Seed) on February 21, 2024.
  • VRG Therapeutics raised $15M (Series B) on February 20, 2024.
  • Colipi raised $1.9M (Seed) on February 19, 2024.
  • FreezeM raised $14M (Series A) on February 15, 2024.
  • SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.

Who to call at Carcinotech Ltd, and when

A new round usually means Carcinotech Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Carcinotech Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Carcinotech Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Carcinotech Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Carcinotech Ltd

Location

ROSLIN INNOVATION CENTRE

Edinburgh, Scotland, United Kingdom

About

Carcinotech is a MedTech company with expertise in manufacturing 3D printed micro-tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Carcinotech’s advanced models provide a platform for rapid, ethical, and accurate drug screening, pre-clinical and personalised medicine testing. Working with global partners, leading pharma companies, surgeons, pathologists, clinicians, and industry-leaders, the goal is to accelerate drug screening and enable delivery of more effective cancer treatments to market. Access to Carcinotech’s robotic and automated manufacturing allows for accelerated production, with models offering high-throughput capabilities. We are a team of like-minded, highly-experienced and determined individuals, all sharing a vision for success. Learn more about our models, get in touch.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Carcinotech Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Carcinotech Ltd's next move

See what Strategic adds

Carcinotech Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.